Psoriasis and autoimmune diseases

All Items

• Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio­markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles

  Jochen H.O. Hoffmann, Christian Knoop, Knut Schäkel, Alexander H. Enk, Eva N. Hadaschik

  adv00462

• Evaluation of the Diagnostic Value of Oesophageal Biopsies for Direct Immunofluorescence Microscopy in Mucous Membrane Pemphigoid

  Kaan Yilmaz, Onur Dikmen, Nina van Beek, Jens U. Marquardt, Martha M. Kirstein, Detlef Zillikens, Enno Schmidt

  adv11947

• Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort

  Thomas Bettuzzi, Hervé Bachelez, Marie Beylot-Barry, Hugo Arlégui, Carle Paul, Manuelle Viguier, Emmanuel Mahé, Nathalie Beneton, Denis Jullien, Marie-Aleth Richard, Pascal Joly, Florence Tubach, Alain Dupuy, Emilie Sbidian, Olivier Chosidow

  adv00665

• Exploring the Role of Adipose Tissue Dysregulation in Vitiligo Pathogenesis: A Body Composition Analysis

  XinYi Shao, Xingyu Pan, Tingqiao Chen, Ziyan Chen, Yuhao Li, Judan Zhong, Ruiyao Wang, Jun Yu, Jin Chen, Yangmei Chen

  adv41018

• Factors Influencing Major Life-Changing Decisions in Patients with Psoriasis: A Cross-sectional Study

  Manuel Sanchez-Diaz, Pablo Díaz-Calvillo, Alberto Soto-Moreno, Alejandro Molina-Leyva, Salvador Arias-Santiago

  adv11640

• Febrile Ulceronecrotic Mucha-Habermann Disease: A Case Report and Review of Literature in the Paediatric Population

  Jue Liu, Jianbo Zhong, Qiaowei Wang, Yinglian Cai, Jian Chen

  adv4806

• Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center

  Linda Davidson, Juul M.P.A. van den Reek, Florence van Hunsel, Elke M.G.J. de Jong; Bart Jan Kullberg

  adv00648

• Guselkumab in Patients with Scalp Psoriasis: A post hoc Analysis of the VOYAGE 2 Phase III Randomized Clinical Trial

  Enikö Sonkoly, Julia-Tatjana Maul, Matteo Megna, Patricia Gorecki, Edmée Crombag, Jozefien Buyze, Laura Savage

  adv18672

• Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis

  Tarja Mälkönen, Pauliina Nuutinen, Taru Hallinen, Erkki Soini, Riikka Nissinen, Christina Wennerstöm, Tapio Rantanen, Johanna H. Hagman, Rauno Harvima, Johanna Höök-Nikanne, Tiina Ilves, Päivi Lintu, Ken Malanin, Iina Soramäki, Kaisa Tasanen, Arja Teho, Katja Vähävihu, Sari Itälinna, Pekka Leinonen, Piia Sarajärvi, Laura Huilaja, Rafael Pasternack

  adv00631

• Happiness Behind the Scenes: Associations between Heuristic Happiness and Related Dimensions in Skin Diseases

  Johanna Weis, Hannah Wecker, Alexander Arnold, Barbara Schuster, Stefanie Ziehfreund, Linda Tizek, Sonja Mittag, Tilo Biedermann, Alexander Zink

  adv5284

• Hidradenitis Suppurativa: Absence of Hyperhidrosis but Presence of a Proinflammatory Signature in Patients’ Sweat

  Verena G. Frings, Nadine Roth, Maxine Gläsel, Boris Bauer, Matthias Goebeler, Dagmar Presser, Andreas Kerstan

  adv00793

• Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients

  Dana Shalmon, Efrat Bar-Ilan, Alon Peled, Shamir Geller, Jonathan Bar, Naama Schwartz, Eli Sprecher, Mor Pavlovsky

  adv26663

• Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

  April W. Armstrong, Elisabeth Riedl, Patrick M. Brunner, Stefano Piaserico, Willie I. Visser, Natalie Haustrup, Bruce W. Konicek, Zbigniew Kadziola, Mercedes Nunez, Alan Brnabic, Christopher Schuster

  adv40556

• IkBζ is a Key Regulator of Tumour Necrosis Factor-a and Interleukin-17A-mediated Induction of Interleukin-36g in Human Keratinocytes

  Sofie Kaas Ovesen, Klaus Schulze-Osthoff, Lars Iversen, Claus Johansen

  adv00386

• Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis

  Sonphet Chirasuthat, Yanisa Ratanapokasatit, Kunlawat Thadanipon, Kumutnart Chanprapaph

  adv40009

• Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid

  Jasper Pruessmann, Wiebke Pruessmann, Maike M. Holtsche, Beke Linnemann, Christoph M. Hammers, Nina van Beek, Detlef Zillikens, Enno Schmidt, Christian D. Sadik

  adv00419

• Impact of Bariatric Surgery on Hidradenitis Suppurativa

  Clothilde Canard, Ana Diaz Cives, Isabelle Gaubil-Kaladjian, Eric Bertin, Manuelle Viguier

  adv00471

• Impact of Bariatric Surgery on Moderate to Severe Psoriasis: A Retrospective Nationwide Registry Study

  Marta Laskowski, Linus Schiöler, Johan Ottosson, Marcus Schmitt-Egenolf, Ann-Marie Wennberg, Torsten Olbers, Kjell Torén, Helena Gustafsson

  adv00487

• Impact of Childhood Onset Psoriasis on Addictive Behaviours, Socioeconomic and Educational Data in Adulthood

  Emmanuel Mahé, Florence Tubach, Denis Jullien, Diep Tran, Carle Paul, Marie Beylot-Barry, Alain Dupuy, Manuelle Viguier, Marie-Aleth Richard, Emilie Sbidian, Nathalie Beneton, Pascal Joly, Olivier Chosidow, Hervé Bachelez

  adv00733

• Impact of Childhood Psoriasis on Caregivers’ Quality of Life, Measured with Family Dermatology Life Quality Index

  Magdalena Żychowska, Adam Reich, Joanna Maj, Alina Jankowska-Konsur, Jacek C. Szepietowski

  adv00244

• Impact of Etanercept on Vitamin D Status and Vitamin D-binding Protein in Bio-naïve Patients with Psoriasis

  Maria Siekkeri Vandikas, Kerstin Landin-Wilhelmsen, Sam Polesie, Martin Gillstedt, Amra Osmancevic

  adv00604

• Impact of the COVID-19 Pandemic on the Mental Health and Quality of Life of Patients with Psoriasis in Tertiary Care; A One-year Follow-up

  Georgia Lada, Hector Chinoy, Peter S. Talbot, Richard B. Warren, C. Elise Kleyn

  adv00814

• Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis

  Rachael M. Hewitt, Rachael L. Pattinson, Lis Cordingley, Christopher E.M. Griffiths, C. Elise Kleyn, Helen McAteer, Julia Schofield, Chris Bundy

  adv00445

• Incidence of Dermatitis Herpetiformis in Sweden 2005 to 2018: A Nationwide Retrospective Cohort Study

  Zeyad Albadri, Doua Al Bayati, Henrike Häbel, Sandra Jerkovic Gulin, Carina Grönhagen, Oliver Seifert

  adv13210

• Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study

  Ireny Y.K. Iskandar, Teng-Chou Chen, Li-Chia Chen, Meng-Sui Lee, Yen-Yun Yang, Ting-Chun Wang, Yu-Chun Hsieh, K. Arnold Chan, Christopher E.M. Griffiths, Darren M. Ashcroft

  adv00807

• Intercellular, Linear Direct Immunofluorescence Staining Pattern of Sweat Glands and Hair Follicles may be Used as a Diagnostic Marker for Pemphigus Vulgaris in Cases where Epidermis is Missing

  Orsolya N. Horvath, Michaela Maurer, Vivian Wietzke, Victoria Fischer, Lars E. French, Miklós Sárdy

  adv40620

• Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: Results from a Register Study

  Axel Svedbom, Mona Ståhle

  adv7138

• IPC 2023 Think Tank: Gunnar Lomholt Symposium

  No authors listed

  adv18471

• Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review

  Wynanda A. van Enst, Ying Chao Weng, Sophie A. C. Wanten, Marieke M.B. Seyger, Ewout M. Baerveldt, Bernd W.M. Arents, Elke M.G.J. de Jong, Juul M.P.A. van den Reek

  adv23901

• Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

  Alice B. Gottlieb, Atul Deodhar, Iain B. Mcinnes, Xenofon Baraliakos, Kristian Reich, Stefan Schreiber, Weibin Bao, Kwaku Marfo, Hanno B. Richards, Luminita Pricop, Abhijit Shete, Vivek Trivedi, Deborah Keefe, Charis C. Papavassilis, Piotr Jagiello, Philemon Papanastasiou, Philip J. Mease, Mark Lebwohl

  adv00698

• Lupus-like skin Eruptions as Indicator of Disease Progression and Poor Outcome in Patients with Haematological Malignancies

  Alexander Kreuter, Bijan Koushk Jalali, Jeannine Meinrath, Frank Oellig

  adv00500

• Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis

  Ahmad Jalili, Henrik Thoning, Marie Y. Jablonski Bernasconi, Kim Papp

  adv12623

• Musculoskeletal Pain in Patients with Psoriasis and its Influence on Health-related Quality of Life: Results from a Danish Population-based Survey

  Sara Kamp Felbo, Lene Terslev, Inge Juul Sørensen, Lone Skov, Claus Zachariae, Mikkel Østergaard

  adv00553

• Neuroimmune Mediators of Pruritus in Hispanic Scalp Psoriatic Itch

  Leigh A. Nattkemper, Zoe M. Lipman, Giuseppe Ingrasci, Claudia Maldonado, Juan Carlos Garces, Enrique Loayza; Gil Yosipovitch

  adv4463

• Notalgia Paresthetica Dermatologist Report of Symptom Burden and Treatment: Results from a Physician Survey

  Brian S. Kim, Sonja Ständer, Kenji Kabashima, Jennifer A. Mohawk, Sherri So, Joana Goncalves, Nilam Shah, Catherine Munera, Joseph C. Punzalan, Romelia Argudo, Mark Lebwohl

  adv39941

• Painless Plaques Evolving to Bullae and Painful Erosions on the Penis: A Quiz

  Alberto Meneguzzo, Roberto Mazzetto, Annalisa Lazzarotto, Stefano Piaserico

  adv00871

• Patient and Tumour Characteristics of Keratoacanthoma in a Large, Community-based Cohort Study from Queensland, Australia

  Agnes Kolmodin, Nirmala P. Pandeya, Catherine M. Olsen, Jean Claude Dusingize, David C. Whiteman, Magdalena Claeson

  adv00469

• Patient Journey of Generalized Pustular Psoriasis: A Real-world Study Using Data-mining Methods and Japanese Claims Data

  Koremasa Hayama, Yahui Tian, Ryoko Iwasaki, Hideki Fujita

  adv11946

• Patient-reported Outcomes and Burden of Disease in Paediatric Patients with Psoriasis: Real-world Data from EU5 and US

  Marieke M.B. Seyger, Amy S. Paller, Michael Sticherling, Teresa Bachhuber, Nicolas Thomas, James Hetherington, James Lucas, Craig Richardson, Matthias Augustin

  adv2544
• 

  Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE Trial

  Enzo Errichetti, Peter Wolf, Saakshi Khattri, Patricia Gorecki, Megan Miller, Jingzhi Jiang, Chenglong Han, Brian Kirby

  adv41053

• Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries

  Sylvia van Beugen, Christina Schut, Jörg Kupfer, Antony P. Bewley, Andrew Y. Finlay, Uwe Gieler, Andrew R. Thompson, Tamara Gracia-Cazaña, Flora Balieva, Bárbara R. Ferreira, Gregor B. Jemec, Lars Lien, Laurent Misery, Servando E. Marron, Sonja Ständer, Claudia Zeidler, Csanád Szabó, Jacek C. Szepietowski, Adam Reich, Amna Elyas, Ilknur K. Altunay, Franz J. Legat, Vesna Grivcheva-Panovska, Dmitry V. Romanov, Andrey N. Lvov, Géraldine Titeca, Francesca Sampogna, Nienke C. Vulink, Lucia Tomás-Aragones, Andrea W.M. Evers, Florence J. Dalgard

  adv6485

• Persistent Skin Symptoms after Diagnosis and on a Long-term Gluten-free Diet in Dermatitis Herpetiformis

  Camilla Pasternack, Kaisa Hervonen, Eriika Mansikka, Timo Reunala, Pekka Collin, Katri Kaukinen, Teea T. Salmi

  adv00555

• Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry

  Simone Cazzaniga, Kristine Heidemeyer, Luigi Naldi

  adv5331

• Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study

  Marieke M.B. Seyger, Matthias Augustin, Michael Sticherling, Teresa Bachhuber, Juanzhi Fang, James Hetherington, James Lucas, Sophie Meakin, Craig Richardson, Amy S. Paller

  adv00660

• Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study

  Christopher Willy Schwarz, Nikolai Loft, Mads Kirchheiner Rasmussen, Christoffer V. Nissen, Tomas Norman Dam, Kawa Khaled Ajgeiy, Alexander Egeberg, Lone Skov

  adv00579

• Prevalence and Incidence of Psoriatic Arthritis among Patients with Psoriasis and Risk Factors for Psoriatic Arthritis in Republic of Korea: A Nationwide Database Cohort Study

  Chul Hwan Bang, Yoon-Seob Kim, Jihye An, Eun Suk Jung, JiYoon Ahn, Jung-Ae Kim, Chul Jong Park

  adv40110

• Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid

  Sharon Baum, Shani Steinberg, Ido Tzanani , Aviv Barzilai , Anna Lyakhovitsky

  adv00888

• Prolonged Sick Leave Before and After Diagnosis of Generalized Pustular Psoriasis: A Swedish Population-based Register Study

  Sofia Löfvendahl, Jenny M. Norlin, Oskar Ericson, Malin Hanno, Marcus Schmitt-Egenolf

  adv6497

• PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries

  Anna Langenbruch, Nicole Mohr, Valerie Andrees, Ihno Kessens, Adam Reich, Magdalena Czarnecka-Operacz, Luis Puig, Esteban Dauden, Lars Iversen, Matthias Augustin

  adv6532

• Psoriasis and Co-morbidity

  Mina Amin, Erica B. Lee, Tsen-Fang Tsai, Jashin J. Wu

  80-86